Neuropathology for the Neuroradiologist: Antoni A and Antoni B Tissue Patterns

References

1. ↵
   Antoni NRE. Über Rückenmarksteumoren und Neurofibrome. Munich: J.F. Bergmann;1920
2. ↵
   Rosai J. Tumors and tumorlike conditions of peripheral nerves. In: Rosai and Ackerman's Surgical Pathology. Edinburgh: Mosby;2004 :2263–75
3. ↵
   Woodruff JM, Kourea HP. Schwannoma. In: World Health Organization Classification of Tumors: Pathology and Genetics of the Nervous System. Lyon: IARC Press;2000 :164–68
4. ↵
   Scheithauer BW, Giannini C. Perineuroma. In: World Health Organization Classification of Tumors: Pathology and Genetics of the Nervous System. Lyon: IARC Press;2000 :169–71
5. ↵
   Almefty R, Webber BL, Arnautovic KI. Intraneural perineurioma of the third cranial nerve: occurrence and identification. Case report. J Neurosurg 2006;104:824–27

   PubMed
6. ↵
   Woodruff JM, Kourea HP. Malignant peripheral nerve sheath tumor (MPNST). In: World Health Organization Classification of Tumors: Pathology and Genetics of the Nervous System. Lyon: IARC Press;2000 :172–74
7. ↵
   Woodruff JM, Selig AM, Crowley K, et al. Schwannoma (neurilemoma) with malignant transformation. A rare, distinctive peripheral nerve tumor. Am J Surg Pathol 1994;18:882–95

   PubMedWeb of Science
8. ↵
   McMenamin ME, Fletcher CD. Expanding the spectrum of malignant change in schwannomas: epithelioid malignant change, epithelioid malignant peripheral nerve sheath tumor, and epithelioid angiosarcoma: a study of 17 cases. Am J Surg Pathol 2001;25:13–25

   PubMedWeb of Science
9. ↵
   Kudo M, Matsumoto M, Terao H. Malignant nerve sheath tumor of acoustic nerve. Arch Pathol Lab Med 1983;107:293–97

   PubMedWeb of Science
10. ↵
    McLean CA, Laidlaw JD, Brownbill DS, et al. Recurrence of acoustic neurilemoma as a malignant spindle-cell neoplasm. Case report. J Neurosurg 1990;73:946–50

    PubMedWeb of Science
11. ↵
    Verocay J. Zur Kenntnis der “Neurofibrome”. Beitrage zur pathologischen Anatomie und zur allgemeinen. Pathologie 1910;48:1–69
12. ↵
    Wippold FJ 2nd, Lammle M, Anatelli F, et al. Neuropathology for the neuroradiologist: palisades and pseudopalisades. AJNR Am J Neuroradiol 2006;27:2037–41

    Abstract/FREE Full Text
13. ↵
    Woodruff JM, Godwin TA, Erlandson RA, et al. Cellular schwannoma: a variety of schwannoma sometimes mistaken for a malignant tumor. Am J Surg Pathol 1981;5:733–44

    PubMed
14. ↵
    Franks AJ. Neurilemoma. In: Diagnostic Manual of Tumors of the Central Nervous System. Edinburgh: Churchill Livingstone;1988 :80–86
15. Ramzy I. Benign schwannoma: demonstration of Verocay bodies using fine needle aspiration. Acta Cytol 1977;21:316–19

    PubMed
16. ↵
    Waggener JD. Ultrastructure of benign peripheral nerve sheath tumors. Cancer 1966;19:699–709

    CrossRefPubMedWeb of Science
17. ↵
    Fisher ER, Vuzevski VD. Cytogenesis of schwannoma (neurilemoma), neurofibroma, dermatofibroma, and dermatofibrosarcoma as revealed by electron microscopy. Am J Clin Pathol 1968;49:141–54

    PubMedWeb of Science
18. ↵
    Cornbrooks CJ, Carey DJ, McDonald JA, et al. In vivo and in vitro observations on laminin production by Schwann cells. Proc Natl Acad Sci U S A 1983;80:3850–54

    Abstract/FREE Full Text
19. ↵
    Cravioto H. The ultrastructure of acoustic nerve tumors. Acta Neuropathol (Berl)1969;12:116–40

    CrossRefPubMed
20. ↵
    Miettinen M, Foidart JM, Ekblom P. Immunohistochemical demonstration of laminin, the major glycoprotein of basement membranes, as an aid in the diagnosis of soft tissue tumors. Am J Clin Pathol 1983;79:306–11

    PubMedWeb of Science
21. ↵
    Baur AM, Gamberger TI, Weerda HG, et al. Laminin promotes differentiation, adhesion and proliferation of cell cultures derived from human acoustic nerve schwannoma. Acta Otolaryngol 1995;115:517–21

    CrossRefPubMed
22. ↵
    Weiss SW, Langloss JM, Enzinger FM. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors. Lab Invest 1983;49:299–308

    PubMedWeb of Science
23. ↵
    Nakamura Y, Becker LE, Marks A. Distribution of immunoreactive S-100 protein in pediatric brain tumors. J Neuropathol Exp Neurol 1983;42:136–45

    PubMedWeb of Science
24. ↵
    Sharma S, Sarkar C, Mathur M, et al. Benign nerve sheath tumors: a light microscopic, electron microscopic and immunohistochemical study of 102 cases. Pathology 1990;22:191–95

    PubMed
25. ↵
    Erlandson RA, Woodruff JM. Peripheral nerve sheath tumors: an electron microscopic study of 43 cases. Cancer 1982;49:273–87

    CrossRefPubMedWeb of Science
26. ↵
    Enzinger FM, Weiss SW. Benign tumors of peripheral nerves. In: Soft Tissue Tumors. St. Louis: Mosby;1995 :821–88
27. ↵
    McLendon RE, Bigner DD, Bigner SH, et al. Intracranial and intraspinal schwannomas (WHO grade I). In: Pathology of Tumors of the Central Nervous System: A Guide to Histologic Diagnosis. London: Arnold;2000 :71–81
28. ↵
    Takahama M. Electron microscopic study of malignant and benign tumors of the human soft tissue. Bull Tokyo Med Dent U 1963;10:281–331
29. ↵
    Kelly PJ, Suddith RL, Hutchison HT, et al. Endothelial growth factor present in tissue culture of CNS tumors. J Neurosurg 1976;44:342–46

    PubMed
30. ↵
    Ackerman LV, Taylor FH. Neurogenous tumors within the thorax: a clinicopathological evaluation of forty-eight cases. Cancer 1951;4:669–91

    CrossRefPubMedWeb of Science
31. ↵
    Sian CS, Ryan SF. The ultrastructure of neurilemoma with emphasis on Antoni B tissue. Hum Pathol 1981;12:145–60

    CrossRefPubMed
32. ↵
    Stout AP. The peripheral manifestations of the specific nerve sheath tumor (neurilemoma). Am J Cancer 1935;24:751–96

    Abstract/FREE Full Text
33. ↵
    Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993;363:515–21

    CrossRefPubMedWeb of Science
34. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;72:791–800

    CrossRefPubMedWeb of Science
35. Hameed M, Chen F, Mahmet K, et al. Schwannoma with a reciprocal t(9;22)(q22;q13). Cancer Genet Cytogenet 2006;164:92–93

    CrossRefPubMed
36. Mertens F, Dal Cin P, De Wever I, et al. Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group. J Pathol 2000;190:31–38

    CrossRefPubMedWeb of Science
37. ↵
    Rao UN, Surti U, Hoffner L, et al. Cytogenetic and histologic correlation of peripheral nerve sheath tumors of soft tissue. Cancer Genet Cytogenet 1996;88:17–25

    CrossRefPubMed
38. ↵
    Chadee DN, Xu D, Hung G, et al. Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein. Proc Natl Acad Sci U S A 2006;103:4463–68

    Abstract/FREE Full Text
39. ↵
    Gronholm M, Muranen T, Toby GG, et al. A functional association between merlin and HEI10, a cell cycle regulator. Oncogene 2006;25:4389–98

    CrossRefPubMedWeb of Science
40. ↵
    Rong R, Tang X, Gutmann DH, et al. Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L. Proc Natl Acad Sci U S A 2004;101:18200–05

    Abstract/FREE Full Text
41. ↵
    Seizinger BR, Rouleau GA, Ozelius LJ, et al. Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell 1987;49:589–94

    CrossRefPubMedWeb of Science
42. ↵
    Gutmann DH, Wu YL, Hedrick NM, et al. Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes. Hum Mol Genet 2001;10:3009–16

    Abstract/FREE Full Text
43. Bajenaru ML, Donahoe J, Corral T, et al. Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes. Glia 2001;33:314–23

    CrossRefPubMedWeb of Science
44. ↵
    Lau N, Feldkamp MM, Roncari L, et al. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma. J Neuropathol Exp Neurol 2000;59:759–67

    PubMedWeb of Science
45. ↵
    Dasgupta B, Li W, Perry A, et al. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes. Cancer Res 2005;65:236–45

    Abstract/FREE Full Text
46. ↵
    Dasgupta B, Yi Y, Chen DY, et al. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. Cancer Res 2005;65:2755–60

    Abstract/FREE Full Text
47. ↵
    Johannessen CM, Reczek EE, James MF, et al. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci U S A 2005;102:8573–78

    Abstract/FREE Full Text
48. ↵
    Gomez-Brouchet A, Delisle MB, Cognard C, et al. Vestibular schwannomas: correlations between magnetic resonance imaging and histopathologic appearance. Otol Neurotol 2001;22:79–86

    CrossRefPubMed
49. ↵
    Jadro-Santel D, Markovic S, Besenski N, et al. Correlative tissue pathology of intracranial neurinomas with computed tomography scans. Neurol Croat 1991;40:13–22

    PubMed
50. ↵
    Charabi S, Klinken L, Mantoni M, et al. Histology and neuro-imaging in cystic acoustic neuromas. Acta Otolaryngol 1993;113:519–23

    PubMed
51. ↵
    Varma DG, Moulopoulos A, Sara AS, et al. MR imaging of extracranial nerve sheath tumors. J Comput Assist Tomogr 1992;16:448–53

    CrossRefPubMed
52. ↵
    Suh JS, Abenoza P, Galloway HR, et al. Peripheral (extracranial) nerve tumors: correlation of MR imaging and histologic findings. Radiology 1992;183:341–46

    PubMedWeb of Science